Found: 7
Select item for more details and to access through your institution.
Mesenchymal Stem Cells Do Not Prevent Antibody Responses against Human α-L-Iduronidase when Used to Treat Mucopolysaccharidosis Type I.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092420
- By:
- Publication type:
- Article
Treatment of Mouse Limb Ischemia with an Integrative Hypoxia-Responsive Vector Expressing the Vascular Endothelial Growth Factor Gene.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033944
- By:
- Publication type:
- Article
α- l-iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice.
- Published in:
- Journal of Gene Medicine, 2015, v. 17, n. 1/2, p. 1, doi. 10.1002/jgm.2818
- By:
- Publication type:
- Article
Synergistic effect of vascular endothelial growth factor and granulocyte colony-stimulating factor double gene therapy in mouse limb ischemia.
- Published in:
- Journal of Gene Medicine, 2010, v. 12, n. 3, p. 310, doi. 10.1002/jgm.1434
- By:
- Publication type:
- Article
Granulocyte-macrophage colony-stimulating factor gene based therapy for acute limb ischemia in a mouse model.
- Published in:
- Journal of Gene Medicine, 2009, v. 11, n. 4, p. 345, doi. 10.1002/jgm.1298
- By:
- Publication type:
- Article
Marsupial morphology of reproduction: South America opossum male model.
- Published in:
- Microscopy Research & Technique, 2013, v. 76, n. 4, p. 388, doi. 10.1002/jemt.22178
- By:
- Publication type:
- Article
Reduction in skeletal muscle fibrosis of spontaneously hypertensive rats after laceration by microRNA targeting angiotensin II receptor.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186719
- By:
- Publication type:
- Article